Home > Insider Trading > Filing (0001104659-14-012353)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367920	Concert Pharmaceuticals Inc.	CNCE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1277503	Yasunori Kaneko	525 University Avenue Palo Alto CA 94301	No	No	Yes	No
1324617	P L Iv Fund Purchaser Qualified Partners Venture Skyline	525 University Avenue Palo Alto CA 94301	No	No	Yes	No
1392103	Skyline Venture Management Iv, Llc	525 University Avenue Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-20	389,380	$0.00	421,752	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-20	530,974	$0.00	952,726	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-20	106,194	$0.00	1,058,920	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-20	150,000	$14.00	1,208,920	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2014-02-20	2,200,000	$0.00	389,380	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-02-20	3,000,000	$0.00	530,974	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-02-20	600,000	$0.00	106,194	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The Series A, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-5.65 basis upon the closing of the issuer's initial public offering without payment of consideration.
Held by Skyline Venture Partners Qualified Purchaser Fund IV L.P. Dr. John G. Freund and Dr. Yasunori Kaneko are Managing Members of Skyline Venture Management IV, LLC, which is the sole general partner of Skyline Venture Partners Qualified Purchaser Fund IV, L.P., and as such may be deemed to share voting and dispositive power with respect to all shares held by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. Drs. Freund and Kaneko disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein. Dr. Freund is a director of the Issuer and, accordingly, files separate Section 16 reports.
Not applicable.